News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
96,892 Results
Type
Article (5062)
Company Profile (20)
Press Release (91802)
Multimedia
Podcasts (16)
Webinars (4)
Section
Business (31215)
Career Advice (70)
Deals (6168)
Drug Delivery (21)
Drug Development (9420)
Employer Resources (10)
FDA (2254)
Job Trends (2946)
News (48174)
Policy (3828)
Tag
Academia (489)
Accelerated approval (32)
Adcomms (8)
Allergies (25)
Alliances (10725)
ALS (59)
Alzheimer's disease (510)
Antibody-drug conjugate (ADC) (128)
Approvals (2253)
Artificial intelligence (295)
Autoimmune disease (40)
Automation (21)
Bankruptcy (13)
Best Places to Work (2675)
BIOSECURE Act (1)
Biosimilars (27)
Biotechnology (17)
Bladder cancer (23)
Brain cancer (22)
Breast cancer (139)
Cancer (1285)
Cardiovascular disease (60)
Career advice (63)
Career pathing (4)
CAR-T (83)
Cell therapy (243)
Cervical cancer (13)
Clinical research (8287)
Collaboration (862)
Compensation (34)
Complete response letters (7)
COVID-19 (454)
CRISPR (50)
C-suite (294)
Cystic fibrosis (30)
Data (1142)
Decentralized trials (1)
Depression (20)
Diabetes (74)
Diagnostics (1385)
Digital health (18)
Diversity (3)
Diversity, equity & inclusion (1)
Drug discovery (144)
Drug pricing (22)
Drug shortages (4)
Duchenne muscular dystrophy (94)
Earnings (11719)
Editorial (9)
Employer branding (1)
Employer resources (9)
Events (9849)
Executive appointments (302)
FDA (3153)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (3)
Frontotemporal dementia (4)
Funding (722)
Gene editing (82)
Generative AI (32)
Gene therapy (230)
GLP-1 (135)
Government (774)
Grass and pollen (1)
Guidances (166)
Healthcare (2813)
HIV (19)
Huntington's disease (21)
IgA nephropathy (31)
Immunology and inflammation (46)
Immuno-oncology (13)
Indications (23)
Infectious disease (509)
Inflammatory bowel disease (34)
Inflation Reduction Act (3)
Influenza (17)
Intellectual property (45)
Interviews (11)
IPO (2388)
IRA (3)
Job creations (382)
Job search strategy (46)
JPM (22)
Kidney cancer (1)
Labor market (10)
Layoffs (75)
Leadership (5)
Legal (272)
Liver cancer (9)
Longevity (7)
Lung cancer (168)
Lymphoma (143)
Machine learning (24)
Management (6)
Manufacturing (316)
MASH (43)
Medical device (2175)
Medtech (2191)
Mergers & acquisitions (4177)
Metabolic disorders (209)
Multiple sclerosis (25)
NASH (6)
Neurodegenerative disease (113)
Neuropsychiatric disorders (10)
Neuroscience (842)
NextGen: Class of 2026 (880)
Non-profit (1062)
Now hiring (5)
Obesity (87)
Opinion (73)
Ovarian cancer (56)
Pain (42)
Pancreatic cancer (39)
Parkinson's disease (80)
Partnered (16)
Patents (75)
Patient recruitment (98)
Peanut (12)
People (9013)
Pharmaceutical (3)
Phase 1 (2520)
Phase 2 (3616)
Phase 3 (3184)
Pipeline (1573)
Policy (42)
Postmarket research (151)
Preclinical (874)
Press Release (32)
Prostate cancer (43)
Psychedelics (4)
Radiopharmaceuticals (71)
Rare diseases (255)
Real estate (919)
Recruiting (3)
Regulatory (3858)
Reports (16)
Research institute (639)
Resumes & cover letters (11)
Rett syndrome (7)
RNA editing (4)
RSV (6)
Schizophrenia (21)
Series A (123)
Series B (91)
Service/supplier (2)
Sickle cell disease (20)
Special edition (6)
Spinal muscular atrophy (31)
Sponsored (10)
Startups (869)
Stomach cancer (6)
Supply chain (23)
Tariffs (10)
The Weekly (16)
Vaccines (182)
Venture capital (28)
Weight loss (47)
Women's health (11)
Worklife (1)
Date
Today (1)
Last 7 days (152)
Last 30 days (654)
Last 365 days (7450)
2026 (829)
2025 (7468)
2024 (7036)
2023 (7623)
2022 (9286)
2021 (10569)
2020 (9379)
2019 (7511)
2018 (5268)
2017 (4679)
2016 (4081)
2015 (4176)
2014 (2601)
2013 (2034)
2012 (2274)
2011 (2323)
2010 (1876)
Location
Africa (85)
Alabama (21)
Alaska (1)
Arizona (50)
Arkansas (4)
Asia (6672)
Australia (823)
California (2296)
Canada (654)
China (327)
Colorado (74)
Connecticut (117)
Delaware (123)
Europe (14560)
Florida (326)
Georgia (41)
Hawaii (2)
Idaho (18)
Illinois (181)
India (17)
Indiana (105)
Iowa (8)
Japan (147)
Kansas (19)
Kentucky (6)
Louisiana (4)
Maine (5)
Maryland (379)
Massachusetts (1914)
Michigan (107)
Minnesota (107)
Missouri (25)
Montana (5)
Nebraska (7)
Nevada (17)
New Hampshire (30)
New Jersey (531)
New Mexico (7)
New York (845)
North Carolina (360)
North Dakota (5)
Northern California (1146)
Ohio (116)
Oklahoma (9)
Oregon (6)
Pennsylvania (480)
Puerto Rico (3)
Rhode Island (19)
South America (112)
South Carolina (8)
Southern California (826)
Tennessee (49)
Texas (295)
United States (8763)
Utah (73)
Virginia (67)
Washington D.C. (11)
Washington State (195)
West Virginia (1)
Wisconsin (38)
Wyoming (1)
96,892 Results for "advamed accel".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
January 29, 2026
·
6 min read
Press Releases
Generation Lab raises $11 million, becoming Accel’s first longevity bet
October 23, 2025
·
1 min read
Press Releases
Rivus Pharmaceuticals Announces New Data from Phase 2 M-ACCEL Trial of HU6 in MASH in Late-Breaker Oral Presentation at AASLD The Liver Meeting® 2025
November 10, 2025
·
8 min read
Drug Development
BridgeBio Announces Durable Month 12 and 18 Phase 2 Cohort 5 Results of Oral Infigratinib in Achondroplasia, and First Participant Consented in ACCEL for Hypochondroplasia
BridgeBio Pharma, Inc. today announced sustained positive results from PROPEL 2, a Phase 2 trial of the investigational therapy infigratinib in children with achondroplasia, demonstrating continued potential best-in-class efficacy and an encouraging safety profile.
June 4, 2024
·
10 min read
Insights
From Awareness to Acceleration: Rare Disease Drug Development Enters a Pivotal Era
Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like MPS II moving into the spotlight.
February 4, 2026
·
3 min read
·
Jennifer Smith-Parker
Business
Baylis Medical’s Kris Shah appointed to AdvaMed Accel Board of Directors
Baylis Medical Company has announced that President and co-Founder Kris Shah has been named to the Advanced Medical Technology Association’s (AdvaMed) Accel Board of Directors.
October 25, 2017
·
1 min read
Sponsored
Accelerating Timelines and Reducing Cost in Early Clinical Drug Development With ICON’s Accelerated Pharmaceutical Solutions
Innovation drives speed in early phase drug development. ICON’s Accelerated Pharmaceutical Solutions integrate advanced formulation design, real-time dose flexibility, and cutting-edge CMC expertise to transform complexity into clarity. By uniting science, technology, and strategy, biotechs can move faster, smarter, and with confidence—turning obstacles into opportunities for breakthrough success.
December 8, 2025
·
5 min read
·
Arjen Akkerman
Deals
Accel Clinical Services expands through acquisition, becomes Southeast clinical research powerhouse
Accel Clinical Services (ACS), the parent company of Accel Research Sites, is excited to announce its acquisition of the assets of AMPLIFY Clinical.
June 29, 2020
·
4 min read
Biotech Bay
GBT Awards $450,000 in ACCEL Grants to Improve Access to Care in Sickle Cell Disease
Global Blood Therapeutics, Inc. has awarded approximately $450,000 to U.S. community-based organizations and institutions as part of the company’s 2021 Access to Excellent Care for Sickle Cell Patients (ACCEL) Grant Program.
June 15, 2021
·
10 min read
Gene editing
FDA Eyes Accelerated Reviews for Gene Editing Therapies
Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to outline his office’s thinking on accelerating gene editing reviews.
November 3, 2025
·
2 min read
·
Tristan Manalac
1 of 9,690
Next